Michael J. Hammons serves as Executive at L2 MEDICAL DEVELOPMENT CO, where they oversee executive responsibilities. Since joining the company, Michael J. Hammons has executed 9 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Nov 18, 2013 involved transacting 2,378,529 shares valued at $0.
Michael J. Hammons currently holds 437,624 shares of L2 MEDICAL DEVELOPMENT CO (SCQO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Michael J. Hammons has been a net neutral trader of SCQO stock. They have purchased $0 and sold $0 worth of shares.
Michael J. Hammons's most recent insider trade was on Nov 18, 2013, when they sold 2,378,529 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Sep 4, 2013 | SCQO | $0 | Other | 437,624 | $N/A | Discretionary |
| Sep 4, 2013 | SCQO | $0 | Other | 816,958 | $N/A | Discretionary |
| Sep 4, 2013 | SCQO | $0 | Other | 54,703 | $N/A | Discretionary |
| Sep 4, 2013 | SCQO | $0 | Other | 270,350 | $N/A | Discretionary |
| Sep 4, 2013 | SCQO | $0 | Other | 184,065 | $N/A | Discretionary |
| Sep 4, 2013 | SCQO | $0 | Other | 112,646 | $N/A | Discretionary |
| Sep 4, 2013 | SCQO | $0 | Other | 2,378,529 | $N/A | Discretionary |